33498784|t|Bayesian Network as a Decision Tool for Predicting ALS Disease.
33498784|a|Clinical diagnosis of amyotrophic lateral sclerosis (ALS) is difficult in the early period. But blood tests are less time consuming and low cost methods compared to other methods for the diagnosis. The ALS researchers have been used machine learning methods to predict the genetic architecture of disease. In this study we take advantages of Bayesian networks and machine learning methods to predict the ALS patients with blood plasma protein level and independent personal features. According to the comparison results, Bayesian Networks produced best results with accuracy (0.887), area under the curve (AUC) (0.970) and other comparison metrics. We confirmed that sex and age are effective variables on the ALS. In addition, we found that the probability of onset involvement in the ALS patients is very high. Also, a person's other chronic or neurological diseases are associated with the ALS disease. Finally, we confirmed that the Parkin level may also have an effect on the ALS disease. While this protein is at very low levels in Parkinson's patients, it is higher in the ALS patients than all control groups.
33498784	51	62	ALS Disease	Disease	MESH:D000690
33498784	86	115	amyotrophic lateral sclerosis	Disease	MESH:D000690
33498784	117	120	ALS	Disease	MESH:D000690
33498784	266	269	ALS	Disease	MESH:D000690
33498784	468	471	ALS	Disease	MESH:D000690
33498784	472	480	patients	Species	9606
33498784	774	777	ALS	Disease	MESH:D000690
33498784	850	853	ALS	Disease	MESH:D000690
33498784	854	862	patients	Species	9606
33498784	911	932	neurological diseases	Disease	MESH:D020271
33498784	957	968	ALS disease	Disease	MESH:D000690
33498784	1001	1007	Parkin	Gene	5071
33498784	1045	1056	ALS disease	Disease	MESH:D000690
33498784	1102	1113	Parkinson's	Disease	MESH:D010300
33498784	1114	1122	patients	Species	9606
33498784	1144	1147	ALS	Disease	MESH:D000690
33498784	1148	1156	patients	Species	9606
33498784	Association	MESH:D000690	5071

